Shaocong Hou

Shaocong Hou

Auto-generated profile, based on publicly available information

Shaocong Hou

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Cell
Verified
Journal Article
Closed access
PLPingping Li
Pingping Li
SLShuainan Liu
Shuainan Liu
MLMin Lu
Min Lu
GBGautum Bandyopadhyay
Gautum Bandyopadhyay
DODayoung Oh
Dayoung Oh
JOJerrold M. Olefsky
Jerrold M. Olefsky

21 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LKLijuan Kong
Lijuan Kong
QZQijin Zhao
Qijin Zhao
XJXiaojing Jiang
Xiaojing Jiang
JHJinping Hu
Jinping Hu
QJQian Jiang
Qian Jiang
PLPingping Li
Pingping Li
β-Cell dysfunction and β-cell loss are hallmarks of type 2 diabetes (T2D). Here, we found that trimethylamine N-oxide (TMAO) at a similar concentration to that found in diabetes could directly decrease glucose-stimulated insulin secretion (GSIS) in MIN6 cells and primary islets from mice or humans. Elevation of TMAO levels impairs GSIS, β-cell proportion, and glucose tolerance in male C57BL/6 J mice. TMAO inhibits calcium transients through NLRP3 inflammasome-related cytokines and induced Serca2 loss, and a Serca2 agonist reversed the effect of TMAO on β-cell function in vitro and in vivo. Additionally, long-term TMAO exposure promotes β-cell ER stress, dedifferentiation, and apoptosis and inhibits β-cell transcriptional identity. Inhibition of TMAO production improves β-cell GSIS, β-cell proportion, and glucose tolerance in both male db/db and choline diet-fed mice. These observations identify a role for TMAO in β-cell dysfunction and maintenance, and inhibition of TMAO could be an approach for the treatment of T2D.

13 March 2017 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
HQHui Qian
Hui Qian
YCYuanying Chen
Yuanying Chen
ZNZongqian Nian
Zongqian Nian
LSLu Su
Lu Su
HYHaoyong Yu
Haoyong Yu
PLPeng Li
Peng Li
Obesity is characterized by aberrant fat accumulation. However, the intracellular signaling pathway that senses dietary fat and leads to fat storage remains elusive. Here, we have observed that the levels of histone deacetylase 6 (HDAC6) and the related family member HDAC10 are markedly reduced in adipose tissues of obese animals and humans. Mice with adipocyte-specific depletion of Hdac6 exhibited increased fat accumulation and reduced insulin sensitivity. In normal adipocytes, we found that reversal of P300/CBP-associated factor–induced (PCAF-induced) acetylation at K56 on cell death-inducing DFFA-like effector C (CIDEC, also known as FSP27) critically regulated lipid droplet fusion and lipid storage. Importantly, HDAC6 deacetylates CIDEC, leading to destabilization and reduced lipid droplet fusion. Accordingly, we observed elevated levels of CIDEC and its acetylated form in HDAC-deficient adipocytes as well as the adipose tissue of obese animals and humans. Fatty acids (FAs) prevented CIDEC deacetylation by promoting the dissociation of CIDEC from HDAC6, which resulted in increased association of CIDEC with PCAF on the endoplasmic reticulum. Control of CIDEC acetylation required the conversion of FAs to triacylglycerols. Thus, we have revealed a signaling axis that is involved in the coordination of nutrient availability, protein acetylation, and cellular lipid metabolic responses.

1 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
QJQian Jiang
Qian Jiang
QZQijin Zhao
Qijin Zhao
YCYibing Chen
Yibing Chen
CMChunxiao Ma
Chunxiao Ma
XPXiaohong Peng
Xiaohong Peng
PLPingping Li
Pingping Li
In diabetes, macrophages and inflammation are increased in the islets, along with β-cell dysfunction. Here, we demonstrate that galectin-3 (Gal3), mainly produced and secreted by macrophages, is elevated in islets from both high-fat diet (HFD)-fed and diabetic db/db mice. Gal3 acutely reduces glucose-stimulated insulin secretion (GSIS) in β-cell lines and primary islets in mice and humans. Importantly, Gal3 binds to calcium voltage-gated channel auxiliary subunit gamma 1 (CACNG1) and inhibits calcium influx via the cytomembrane and subsequent GSIS. β-Cell CACNG1 deficiency phenocopies Gal3 treatment. Inhibition of Gal3 through either genetic or pharmacologic loss of function improves GSIS and glucose homeostasis in both HFD-fed and db/db mice. All animal findings are applicable to male mice. Here we show a role of Gal3 in pancreatic β-cell dysfunction, and Gal3 could be a therapeutic target for the treatment of type 2 diabetes.

28 July 2017 in BioEssays
Verified
Journal Article
Closed access
PDF file
AJAndrew M. F. Johnson
Andrew M. F. Johnson
SHShaocong Hou
Shaocong Hou
PLPingping Li
Pingping Li

1 February 2013 in Peptides
Verified
Journal Article
Closed access
GHGuo-Jiang Hou
Guo-Jiang Hou
CLCai-Na Li
Cai-Na Li
SLShuai-Nan Liu
Shuai-Nan Liu
YHYi Huan
Yi Huan
QLQuan Liu
Quan Liu
ZSZhu-Fang Shen
Zhu-Fang Shen